person

Hüsnü B.

Country
Germany
Department
Augenheilkunde

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
15
Sites with multiple studies

Has run more than one trial at 15 of 37 partner sites.

Specializations

Breast Cancer

Clinical research in breast cancer spans HER2-positive, HER2-negative, hormone receptor-positive, triple-negative, and PIK3CA-mutated disease, with interest in both early and advanced settings. The focus includes postoperative residual disease, neoadjuvant treatment, adjuvant escalation, and metastatic disease control.

  • HER2-targeted therapy
  • Endocrine therapy
  • CDK4/6 inhibition
  • Antibody-drug conjugates

Work in this area also includes treatment strategies for high-risk disease, ctDNA-positive recurrence, and therapy selection after resistance to prior endocrine or anti-HER2 treatment.

Gynecologic Oncology

Research activity covers epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, particularly in newly diagnosed advanced-stage disease. The therapeutic emphasis is on systemic disease control in combination with surgery and chemotherapy.

  • Platinum-based chemotherapy
  • Anti-angiogenic therapy
  • PARP inhibition
  • Maintenance treatment

Interest extends to advanced-stage disease management, maintenance approaches after initial treatment, and biomarker-informed therapeutic selection in ovarian malignancies.

Colorectal Cancer

Clinical involvement in colon cancer and rectal cancer includes locally advanced and stage II to III disease, with a particular focus on treatment around surgery. The research landscape reflects interest in improving disease control before and after resection.

  • Preoperative systemic therapy
  • Adjuvant treatment
  • ctDNA-guided management
  • Recurrence risk reduction

This area includes evaluation of treatment strategies for node-positive and locally advanced disease, with attention to personalized postoperative decision-making.

Retinal Disease

Ophthalmic research includes diabetic macular edema and wet age-related macular degeneration, reflecting a therapeutic interest in retinal vascular disease and vision preservation. The clinical focus is centered on intravitreal treatment approaches for chronic macular pathology.

  • Intravitreal therapy
  • Visual acuity outcomes
  • Anti-VEGF treatment
  • Macular edema

These studies address retinal disease burden in conditions associated with diabetes and neovascular degeneration.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.